|
US$179.00 ยท In stock
Delivery: <= 3 days. True-PDF full-copy in English will be manually translated and delivered via email.
YY/T 1811-2022: Complement 4 testing kit (immunoturbidimetric method)
Status: Valid
| Standard ID | Contents [version] | USD | STEP2 | [PDF] delivered in | Standard Title (Description) | Status | PDF |
| YY/T 1811-2022 | English | 179 |
Add to Cart
|
3 days [Need to translate]
|
Complement 4 testing kit (immunoturbidimetric method)
| Valid |
YY/T 1811-2022
|
PDF similar to YY/T 1811-2022
Basic data | Standard ID | YY/T 1811-2022 (YY/T1811-2022) | | Description (Translated English) | Complement 4 testing kit (immunoturbidimetric method) | | Sector / Industry | Medical Device & Pharmaceutical Industry Standard (Recommended) | | Classification of Chinese Standard | C44 | | Word Count Estimation | 8,893 | | Issuing agency(ies) | State Drug Administration | YY/T 1811-2022: Complement 4 testing kit (immunoturbidimetric method)---This is a DRAFT version for illustration, not a final translation. Full copy of true-PDF in English version (including equations, symbols, images, flow-chart, tables, and figures etc.) will be manually/carefully translated upon your order.
ICS 11.100.10
CCSC44
People's Republic of China Pharmaceutical Industry Standard
Complement 4 Assay Kit (Immunoturbidimetry)
Published on 2022-05-18
2023-06-01 Implementation
Released by the State Drug Administration
foreword
This document is in accordance with the provisions of GB/T 1.1-2020 "Guidelines for Standardization Work Part 1.Structure and Drafting Rules of Standardization Documents"
drafted.
Please note that some content of this document may be patented. Publication of this document
Institutions do not assume responsibility for identifying patents.
This document is proposed by the State Drug Administration.
This document is under the jurisdiction of the National Standardization Technical Committee for Medical Clinical Laboratory and In Vitro Diagnostic Systems (SAC/TC136).
This document was drafted by. Chongqing Medical Device Quality Inspection Center, Chongqing Zhongyuan Huiji Biotechnology Co., Ltd., Beijing Leadman Biochemical
Co., Ltd., Roche Diagnostics (Shanghai) Co., Ltd., Shandong Brocade Biological Industry Co., Ltd.
The main drafters of this document. He Lechun, Yi Weijing, Ren Yikun, Lai Liulian, Xie Qinghua.
Complement 4 Assay Kit (Immunoturbidimetry)
1 Scope
This document specifies the requirements, test methods and identification, labels and instructions for use, packaging,
Transport and storage.
This document applies to the determination of complement 4 in human serum or plasma by immunoturbidimetry (immunotransmission turbidimetry and immune nephelometry).
Kits for quantitative detection, including kits used on semi-automatic, fully automatic biochemical analyzers or specific protein analyzers.
2 Normative references
The contents of the following documents constitute essential provisions of this document through normative references in the text. Among them, dated citations
documents, only the version corresponding to that date applies to this document; for undated references, the latest edition (including all amendments) applies to
this document.
GB/T 191 Graphical signs of packaging, storage and transportation
GB/T 21415 Metrological traceability of measurement calibrators and control substance assignments in biological samples of in vitro diagnostic medical devices
origin
GB/T 29791.1 Information provided by manufacturers of in vitro diagnostic medical devices (labeling) Part 1.Terms, definitions and general
Require
GB/T 29791.2 Information provided by manufacturers of in vitro diagnostic medical devices (labeling) Part 2.In vitro diagnostic reagents for professional use
3 Terms and Definitions
Terms and definitions defined in GB/T 29791.1-2013 apply to this document.
4 Requirements
4.1 Appearance
Manufacturers should specify appropriate appearance requirements according to the packaging characteristics of products. Generally, the composition and properties of each component of the kit should be included;
Packaging, labelling and other requirements.
4.2 Net content
The net content of liquid reagents should not be less than the marked value.
4.3 Reagent blank absorbance
The absorbance of the reagent blank should meet the requirements claimed by the manufacturer.
NOTE. For immunoturbidimetry only.
4.4 Analytical Sensitivity
Analytical sensitivity should meet the requirements claimed by the manufacturer.
Tips & Frequently Asked Questions:Question 1: How long will the true-PDF of YY/T 1811-2022_English be delivered?Answer: Upon your order, we will start to translate YY/T 1811-2022_English as soon as possible, and keep you informed of the progress. The lead time is typically 1 ~ 3 working days. The lengthier the document the longer the lead time. Question 2: Can I share the purchased PDF of YY/T 1811-2022_English with my colleagues?Answer: Yes. The purchased PDF of YY/T 1811-2022_English will be deemed to be sold to your employer/organization who actually pays for it, including your colleagues and your employer's intranet. Question 3: Does the price include tax/VAT?Answer: Yes. Our tax invoice, downloaded/delivered in 9 seconds, includes all tax/VAT and complies with 100+ countries' tax regulations (tax exempted in 100+ countries) -- See Avoidance of Double Taxation Agreements (DTAs): List of DTAs signed between Singapore and 100+ countriesQuestion 4: Do you accept my currency other than USD?Answer: Yes. If you need your currency to be printed on the invoice, please write an email to [email protected]. In 2 working-hours, we will create a special link for you to pay in any currencies. Otherwise, follow the normal steps: Add to Cart -- Checkout -- Select your currency to pay.
|